Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

5 treatments under study, led by Laboratory Biomarker Analysis

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Terminated1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT02140021Not ApplicableTerminated

Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer

NCT04269837Not ApplicableCompleted

Sexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic Cancer

Showing all 2 trials

Research Network

Common Treatments

  • Laboratory Biomarker Analysis1
  • Counseling1
  • Questionnaire Administration1
  • Biospecimen Collection1
  • Qualityoflife Assessment1

Active Sponsors

  • National Cancer Institute (NCI)1
  • Ohio State University Comprehensive Cancer Center1
  • M.D. Anderson Cancer Center1

Top Investigators

Related Conditions

  • Stage Ib1 Cervical Cancer Ajcc V82
  • Stage Ii Cervical Cancer Ajcc V82
  • Stage Ib Cervical Cancer Ajcc V82
  • Stage Ib Vaginal Cancer Ajcc V82
  • Stage Ii Vulvar Cancer Ajcc V82

Activity Timeline